1. Home
  2. INOD vs MNKD Comparison

INOD vs MNKD Comparison

Compare INOD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$59.69

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.59

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INOD
MNKD
Founded
1988
1991
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
1993
2004

Fundamental Metrics

Financial Performance
Metric
INOD
MNKD
Price
$59.69
$5.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$91.67
$10.08
AVG Volume (30 Days)
1.1M
3.7M
Earning Date
02-19-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
62.46
23.47
EPS
1.01
0.10
Revenue
$238,467,000.00
$313,787,000.00
Revenue This Year
$48.85
$21.40
Revenue Next Year
$25.93
$25.03
P/E Ratio
$58.96
$55.78
Revenue Growth
73.57
17.43
52 Week Low
$26.41
$3.38
52 Week High
$93.85
$6.51

Technical Indicators

Market Signals
Indicator
INOD
MNKD
Relative Strength Index (RSI) 50.77 46.52
Support Level $56.91 $5.03
Resistance Level $65.65 $6.05
Average True Range (ATR) 4.73 0.29
MACD -0.07 -0.02
Stochastic Oscillator 36.42 35.04

Price Performance

Historical Comparison
INOD
MNKD

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: